Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AIMS: Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. METHODS: There were 3105 placebo-treated ACE participants with requisite data for model development. Clinically relevant variables, and those showing nominal univariate association with new-onset diabetes (P 

Original publication

DOI

10.1111/1753-0407.13175

Type

Journal article

Journal

J Diabetes

Publication Date

10/2021

Volume

13

Pages

817 - 826

Keywords

2型糖尿病, coronary heart disease, impaired glucose tolerance, risk prediction, type 2 diabetes mellitus, 冠心病, 糖耐量受损, 风险预测, Acarbose, Adrenal Cortex Hormones, Aged, Algorithms, Blood Glucose, Body Mass Index, China, Coronary Disease, Diabetes Mellitus, Type 2, Double-Blind Method, Fasting, Female, Glucose Intolerance, Glycated Hemoglobin A, Humans, Male, Middle Aged, Placebos, Prospective Studies, Reproducibility of Results, Risk Factors, Sodium Chloride Symporter Inhibitors